JPRN-UMIN000006474
Completed
N/A
A clinical study on the safety and efficacy of accelerated partial breast irradiation in breast-conserving therapy - Accelerated partial breast irradiation in breast-conserving therapy
Department of Radiation Oncology and Image-applied Therapy, Graduate School of Medicine, Kyoto University0 sites50 target enrollmentDecember 1, 2011
ConditionsBreast cancer
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Breast cancer
- Sponsor
- Department of Radiation Oncology and Image-applied Therapy, Graduate School of Medicine, Kyoto University
- Enrollment
- 50
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Simultaneous or metachronous (within 5 years) double cancers. 2\) Metachronous or simultaneous bilateral breast cancers 3\) Infection with systemic therapy indicated. 4\) Body temperature of 38 or more degrees Celsius. 5\) Psychosis. 6\) Uncontrollable diabetes mellitus or administration of insulin. 7\) Scleroderma, systemic lupus erythematosus, dermatomyositis, or polymyositis. 8\) Systemic steroids medication. 9\) Immunosuppressant for active collagen disease. 10\) History of severe heart disease, heart failure, myocardial infarction within 6 months or attack of angina pectoris within 6 months. 11\) Interstitial pneumonia, pulmonary fibrosis, or severe emphysema. 12\) Women during pregnancy, possible pregnancy or breast\-feeding.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
A Clinincal study to assess the effect of an ayurvedic polyherbal formulation in the treating patients with flu like symptomsHealth Condition 1: J111- Influenza due to unidentified influenza virus with other respiratory manifestationsCTRI/2020/12/029600Clinfound Clinical Research Services Pvt Ltd30
Completed
Phase 3
BS054 Clinical StudyJPRN-jRCT2092220032Boston Scientific Japan K.K.20
Completed
Phase 2
Role of GastriCare in Digestive wellbeingHealth Condition 1: null- Subjects who have clinical symptoms of dyspepsia, upper abdominal pain, heart burn, bloating, indigestion, flatulence, abdominal distension, belching and fullness after mealCTRI/2018/04/013249The Himalaya Drug Company60
Withdrawn
N/A
Clinical investigation of the safety and efficacy of ALIMAXX-B biliary stent for bile duct obstructioCBD obstructionmalignant biliary obstruction10018008NL-OMON31943Alveolus, Inc.10
Not Yet Recruiting
Phase 4
To evaluate the Safety and Efficacy of ACELABS SerumCTRI/2024/02/063322Bright Diva Pte. Ltd.